Skip to content
COA & Batch Documentation Available Explore Research Peptides
Research Grade Independently Tested

Selank

Verified Synthesis Batch COA Available
≥ 99% (HPLC) CAS 129954-34-3 C₃₃H₅₇N₁₁O₉
$92.99 AUD · GST incl.
  • Certificate of Analysis available for every batch
  • Form: Lyophilised Powder
  • Storage: 2°C-8°C (Refrigerated)
  • Australia-wide, discreet tracked dispatch
  • Research Use Only - not for human or veterinary use

Selank is a man-made research peptide which is used extensively in the fields of neuroscience, neurochemistry, and behavior study. Selank has been developed as an analog of the immunomodulatory peptide called tuftsin and is being studied because of its potential role in neurotransmission, stress pathways, cognition, and the GABAergic pathway.

The Selank 10mg research version is a specified amount of lyophilized peptide which can be used in laboratory research. The research interest in Selank continues growing with studies of interaction related to GABA signaling, gene expression, monoamine signaling, neuroplasticity, and other CNS-related pathways.

While Selank is often talked about in online circles in connection with anxiety, stress, and cognition, one has to be very careful with existing information. Many publications relating to Selank’s mechanism of action are preclinical and cannot be considered proven therapeutically effective.

What Is Selank?

Selank is a synthetic heptapeptide consisting of seven amino acids. Its sequence is:

Thr-Lys-Pro-Arg-Pro-Gly-Pro

The compound was created using tuftsin, which is a naturally occurring tetrapeptide linked to immune system function. Through altering the sequence of the peptide, a more stable compound was made available for studies in neurobiological and biochemical assays.

Selank is typically regarded as a regulating or nootropic research peptide. The focus of scientific inquiry is the possible interactions of the compound with neurotransmitter systems and molecular processes related to stress, memory, learning, and neuronal communication.

Australian scientists who are looking for Selank 10 mg or Selank peptide Australia should be aware of the distinction between laboratory research material and an approved drug product.

Why Is Selank Being Studied?

Selank is being studied for reasons such as the possible involvement of Selank in interactions with multiple biological systems instead of functioning via one single molecular target.

Some areas of major investigation are:

  • GABAergic neurotransmission and receptor-related signaling
  • Gene expression concerning neurotransmitter pathways
  • Stress response and behavioral models
  • Memory, learning and cognition studies
  • Dopaminergic and serotonergic signaling
  • Neuroplasticity and neuronal communication
  • Immune signaling and cytokine regulation
  • Peptide stability and metabolism

An area where Selank has aroused considerable scientific curiosity is its potential interaction with the GABAergic system. Research work has found alterations in gene expression in neurotransmission, thereby suggesting that Selank may regulate GABAergic signaling by intricate modes of modulation.

It should be noted that these findings are all part of a developing field of study, and lab and animal findings do not equate clinical utility or safety in humans.

How Does Selank Work?

The exact mechanisms of Selank are not fully known yet. Scientists believe now that the biological effect of this substance might be explained by the functioning of several signaling pathways.

Scientists have studied the possible effects of the interaction of Selank with the GABAergic system, which takes part in the inhibitory neurotransmission process. Experimental researches were also conducted with the genes of neurotransmitter receptors, transporters, ion channels and neuronal signaling.

Scientists studied such research areas as the possible effect of Selank on dopamine and serotonin pathways, neurotrophic and immune mechanisms. All these mechanisms might explain scientists why Selank became a subject for the study in the fields of neuropeptides and behavior.

But it will be more correct to say that these pathways are only research hypothesis and experiments observations.

Understanding Selank Dosage

There is a high demand for Selank dosage in the internet community, while research dosage and dosage for humans are two different things.

For research purposes, the required amount will depend on many factors including the animal model used, study design, type of assay used, sample size and objectives of research. Selank 10 mg vial is a measure of total amount of peptide in the vial; it does not imply a dosage recommendation.

Research protocols should be developed based on scientific literature, proper methodologies and institutional guidelines. Peptide concentration, solvent compatibility, storage conditions and sensitivity of the assay can influence research results.

Selank 10 mg research product cannot be treated as a prescribed medication with a set dosage regimen.

Selank and Research Quality

Quality is a crucial factor in the study of peptides. For any reliable research, the quality of the material that needs to be analyzed must be known.

The factors that need to be considered while analyzing the quality of Selank peptide include the following:

  • Batch specific Certificate of Analysis data
  • HPLC data to test purity
  • Mass Spectrometry data for molecular identity confirmation
  • Batch/Lot designation
  • Quantity of peptide per vial
  • Packaging/Storage information
  • Documentation and traceability
  • Supplier transparency and quality control information

Purity % alone cannot be considered as a total quality analysis of the sample. Researchers should analyze whether the analytical data matches with the particular batch.

Selank in Australia

Interest in Selank Australia and research peptides Australia has grown along with interest in peptide substances in general.

Consumers and researchers in Australia need to exercise caution in distinguishing between legitimate research substances and those that are advertised with unfounded therapeutic claims. This will vary based on the product and intended use.

The Therapeutic Goods Administration has heightened their scrutiny of unauthorized peptide products. Any products being sold as having therapeutic uses could come under the jurisdiction of Australian therapeutic goods law.

Prior to importing any Selank in Australia, it is prudent to determine the current requirements for such an activity by independent means.

What to Consider Before You Buy Selank

When you plan to purchase Selank for legitimate research purposes, pay attention to material quality and documentation, not marketing promises.

Check whether there is the information about the analytical procedures performed on the specific batch of the product and its characteristics. Make sure that the Certificate of Analysis is linked to the correct batch and there is information about HPLC and mass spectrometry analysis.

Researchers also need to think about package integrity, storage and delivery conditions, as well as technical data on the product.

Do not trust sellers who promise guaranteed results in anxiety reduction, brain function enhancement, or any other medical effects. Legitimate research peptides cannot be promoted as the preliminary scientific studies have confirmed their therapeutic effects.

For the case of research with Selank 10mg, material quality and documentation are critical.

Safety and Current Research

Current evidence for the use of Selank remains insufficient when compared to other drugs which have been used extensively. Research has been conducted on the effects of Selank in relation to neurotransmission, gene expression, and behavior, but independent clinical research is required to determine potential effects, restrictions, and safety.

It would be misleading to expect results of cell-based research, animal testing, and experiments to have the same effects as seen in human patients.

Australian agencies have also issued warnings against the use of unapproved peptide substances, warning of dangers that are associated with incorrect labeling, contamination, unknown composition, and poor manufacturing procedures.

Selank should be considered and referred to accurately. It represents an interesting area of research in peptide science and neuroscience.

Frequently Asked Questions

Selank is a synthetic seven-amino-acid peptide developed from the naturally occurring peptide tuftsin. It is studied in neuroscience, neurotransmission and behavioural research.

Selank 10mg refers to a vial containing a total of 10 milligrams of peptide material. The amount describes vial content and does not represent a recommended human dose.

Researchers investigate Selank for its possible interactions with GABAergic signalling, neurotransmitter pathways, gene expression, cognitive processes and stress-related biological mechanisms.

Experimental studies suggest that Selank may influence GABA-related neurotransmission and gene-expression pathways. The exact mechanism remains under investigation.

Selank is commonly described in research discussions as a nootropic or regulatory peptide because of scientific interest in cognition, neuronal signalling and behavioural processes. This classification does not establish approved therapeutic effects.

Researchers and consumers should verify the current regulatory position directly through relevant Australian authorities. Selank should not be assumed to be an approved therapeutic product simply because it is available online.

Important considerations include batch-specific COA documentation, HPLC purity data, mass spectrometry identity testing, batch traceability, packaging integrity and appropriate storage information.

Storage requirements should follow the product's batch documentation and supplier specifications. Peptide materials commonly require protection from heat, moisture and light, but exact conditions should be verified for the specific product.

There is no universal research concentration suitable for every experiment. Laboratory protocols depend on the experimental model, assay, concentration range and study objective. Human-use instructions should not be inferred from research vial strength.

Peptide identity, purity, batch consistency and handling conditions can influence experimental results. Reliable analytical documentation supports reproducibility and helps researchers evaluate whether the tested material matches the stated specifications.

Notice

Selank is an investigational peptide intended for scientific research purposes. It should not be presented as an approved therapeutic medicine in Australia. Researchers and organisations should verify the current regulatory requirements applicable to their intended research, importation, possession and supply activities.

Disclaimer

This content is provided for educational, scientific and research-information purposes only. It does not provide medical advice, treatment recommendations or personal dosage instructions. Available evidence concerning Selank includes preclinical research and ongoing or completed clinical investigations. Further research is required to better understand its safety, pharmacology and potential efficacy for specific research applications.

References

5 sources
  1. Vyunova TV, Andreeva LA, Shevchenko KV, et al.
    The Molecular Aspects of Heptapeptide Selank Biological Activity.
    Current Protein & Peptide Science. 2018;19(6):613-621.
    PubMed: https://pubmed.ncbi.nlm.nih.gov/30255741/
  2. Volkova AA, Shadrina MI, Kolomin TA, et al.
    Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission.
    Frontiers in Pharmacology. 2016;7:31.
    Full Text: https://pmc.ncbi.nlm.nih.gov/articles/PMC4757669/
  3. Medvedev VE, et al.
    A Comparison of the Anxiolytic Effect and Tolerability of Selank and Phenazepam in the Treatment of Anxiety Disorders.
    Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2014;114(7):17-22.
    PubMed: https://pubmed.ncbi.nlm.nih.gov/25176261/
  4. Kozlovskiy SA, Pyasik MM, Vartanov AV, et al.
    Functional Connectomic Approach to Studying Selank and Semax Effects.
    Doklady Biochemistry and Biophysics. 2020.
    PubMed: https://pubmed.ncbi.nlm.nih.gov/32342318/
  5. Australian Government, Therapeutic Goods Administration (TGA).
    TGA Warning on the Risks of Importing Unapproved Peptide Products.
    Therapeutic Goods Administration. 7 May 2026.
    TGA: https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/tga-warning-risks-importing-unapproved-peptide-products
Medically & Scientifically Reviewed By

Dr. Priyanka Goel

Scientific & Medical Content Reviewer

Information last reviewed: 9 Jul 2026

The products and information offered by Verified Peptides are intended for legitimate laboratory, analytical and scientific research applications only. Products are not for human or veterinary use, and are not therapeutic goods. The results of studies should be interpreted based on the experimental model and the limitations of the existing evidence base.

Product information and educational materials are provided only for research and informational purposes and must not be interpreted as medical advice, diagnosis or treatment.

Added to cart
View Cart Checkout